Anti-idiotypic nanobody-alkaline phosphatase fusion proteins: Development of a one-step competitive enzyme immunoassay for fumonisin B1 detection in cereal

Anal Chim Acta. 2016 Jun 14:924:53-59. doi: 10.1016/j.aca.2016.03.053. Epub 2016 Apr 7.

Abstract

A rapid and sensitive one-step competitive enzyme immunoassay for the detection of FB1 was developed. The anti-idiotypic nanobody-alkaline phosphatase (Ab2β-Nb-AP) was validated by the AP enzyme activity and the properties of bounding to anti-FB1-mAb (3F11) through colorimetric and chemiluminescence analyses. The 50% inhibitory concentration and the detection limit (LOD) of colorimetric enzyme-linked immunosorbent assay (ELISA) for FB1 were 2.69 and 0.35 ng mL(-1), respectively, with a linear range of 0.93-7.73 ng mL(-1). The LOD of the chemiluminescence ELISA (CLIA) was 0.12 ng mL(-1), and the IC50 was 0.89 ± 0.09 ng mL(-1) with a linear range of 0.29-2.68 ng mL(-1). Compared with LC-MS/MS, the results of this assay indicated the reliability of the Ab2β-Nb-AP fusion protein based one-step competitive immunoassay for monitoring FB1 contamination in cereals. The Ab2β-Nb-AP fusion proteins have the potential to replace chemically-coupled probes in competitive enzyme immunoassay systems.

Keywords: Anti-idiotypic antibody; Nanobody; One-step immunoassay.

MeSH terms

  • Alkaline Phosphatase / immunology*
  • Fumonisins / immunology*
  • Immunoenzyme Techniques / methods*
  • Single-Domain Antibodies / immunology*

Substances

  • Fumonisins
  • Single-Domain Antibodies
  • fumonisin B1
  • Alkaline Phosphatase